These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 26843788)

  • 21. Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes.
    Kumar P; Subramaniyam G
    Cytokine; 2015 Feb; 71(2):366-76. PubMed ID: 25510901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis.
    Chen P; Tang X
    Front Immunol; 2021; 12():803101. PubMed ID: 35003133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ursolic acid regulates gut microbiota and corrects the imbalance of Th17/Treg cells in T1DM rats.
    Chen W; Yu Y; Liu Y; Song C; Chen H; Tang C; Song Y; Zhang X
    PLoS One; 2022; 17(11):e0277061. PubMed ID: 36327331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.
    Dolpady J; Sorini C; Di Pietro C; Cosorich I; Ferrarese R; Saita D; Clementi M; Canducci F; Falcone M
    J Diabetes Res; 2016; 2016():7569431. PubMed ID: 26779542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
    Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
    Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the gastrointestinal ecosystem in the development of type 1 diabetes.
    Daft JG; Lorenz RG
    Pediatr Diabetes; 2015 Sep; 16(6):407-18. PubMed ID: 25952017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.
    Starosz A; Jamiołkowska-Sztabkowska M; Głowińska-Olszewska B; Moniuszko M; Bossowski A; Grubczak K
    Front Immunol; 2022; 13():958430. PubMed ID: 36091019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
    Saxena A; Desbois S; Carrié N; Lawand M; Mars LT; Liblau RS
    J Immunol; 2012 Sep; 189(6):3140-9. PubMed ID: 22904307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crucial role of early-life gut microbiota in the development of type 1 diabetes.
    Zhou H; Sun L; Zhang S; Zhao X; Gang X; Wang G
    Acta Diabetol; 2021 Mar; 58(3):249-265. PubMed ID: 32712802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis.
    Dedrick S; Sundaresh B; Huang Q; Brady C; Yoo T; Cronin C; Rudnicki C; Flood M; Momeni B; Ludvigsson J; Altindis E
    Front Endocrinol (Lausanne); 2020; 11():78. PubMed ID: 32174888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential route of Th17/T
    Karri SK; Sheela A
    Br J Biomed Sci; 2017 Jan; 74(1):8-15. PubMed ID: 28074676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut Microbiota and Type 1 Diabetes.
    Han H; Li Y; Fang J; Liu G; Yin J; Li T; Yin Y
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29584630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of type 1 diabetes on the composition and functional potential of gut microbiome in children and adolescents: possible mechanisms, current knowledge, and challenges.
    Mokhtari P; Metos J; Anandh Babu PV
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34101547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiota in type 1 diabetes: friend or foe?
    Gavin PG; Hamilton-Williams EE
    Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):207-212. PubMed ID: 31145129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
    Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
    J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-life exposure to gut microbiota from disease-protected mice does not impact disease outcome in type 1 diabetes susceptible NOD mice.
    Mullaney JA; Stephens JE; Geeling BE; Hamilton-Williams EE
    Immunol Cell Biol; 2019 Jan; 97(1):97-103. PubMed ID: 30191611
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the balance between CD4(+)Foxp3(+) regulatory T cells and CD4(+)IL17A(+) Th17 cells in patients with type 1 diabetes.
    Ryba-Stanisławowska M; Skrzypkowska M; Myśliwiec M; Myśliwska J
    Hum Immunol; 2013 Jun; 74(6):701-7. PubMed ID: 23395729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-17 immunity in human type 1 diabetes.
    Honkanen J; Nieminen JK; Gao R; Luopajarvi K; Salo HM; Ilonen J; Knip M; Otonkoski T; Vaarala O
    J Immunol; 2010 Aug; 185(3):1959-67. PubMed ID: 20592279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th1-Like ICOS+ Foxp3+ Treg Cells Preferentially Express CXCR3 and Home to β-Islets during Pre-Diabetes in BDC2.5 NOD Mice.
    Kornete M; Mason ES; Girouard J; Lafferty EI; Qureshi S; Piccirillo CA
    PLoS One; 2015; 10(5):e0126311. PubMed ID: 25946021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.